Oscillating Positive Expiratory Pressure Devices Market Analysis and Forecast to 2032

Oscillating Positive Expiratory Pressure Devices Market Analysis and Forecast to 2032: By Product Type (Face Mask PEP Devices, Mouthpiece PEP Devices, Bottle PEP Devices), Indication (COPD & Asthma, Bronchitis, Cystic Fibrosis, Others), End-user (Hospital & Clinics, Ambulatory Surgical Centers, Others), and Region

The oscillating positive expiratory pressure devices market was valued at USD 125.7 million in 2022 and it is anticipated to grow further till USD 208.9 million by 2032, at a CAGR of 5.2% during the forecast period.

The machines that are utilized to remove secretions from the airways are known as oscillating positive expiratory pressure (OPEP) devices. People with chronic respiratory conditions like COPD, cystic fibrosis, and chronic bronchitis among others can benefit from it. The device is used to remove excess mucus that these illnesses produce. It facilitates breathing and helps to relax the lungs' walls.

Market Trends and Drivers

The increasing prevalence of cystic fibrosis and chronic obstructive pulmonary disease (COPD) has led to a surge in demand for mucous clearing devices, with oscillating positive expiratory pressure (OPEP) devices spearheading the growth of the market. These conditions often result in the accumulation of thick mucus in the airways, leading to breathing difficulties and decreased lung function. OPEP devices offer an effective solution by generating oscillations during exhalation, which helps to mobilize and loosen the mucus, facilitating its removal and improving airway clearance. As awareness of the benefits of these devices continues to spread among healthcare professionals and patients alike, the OPEP devices market is poised to experience significant expansion to meet the rising needs of individuals seeking better management of cystic fibrosis and COPD.

Market Restraints and Challenges

The oscillating positive expiratory pressure (OPEP) devices market is facing challenges in its growth trajectory, primarily due to two key factors: low awareness and high cost. Despite the potential benefits these devices offer in improving respiratory health, there remains a lack of sufficient awareness among healthcare professionals and patients alike. This limited awareness hampers the adoption of OPEP devices, as potential users may not fully understand their advantages. Moreover, the relatively high cost associated with these devices also acts as a significant restraint on market growth, making them less accessible to a broader population. To overcome these obstacles, concerted efforts are required from manufacturers and healthcare stakeholders to increase awareness through educational initiatives, while also exploring avenues to make these devices more cost-effective and affordable to a consumers.

Global Oscillating Positive Expiratory Pressure Devices Market Segmental Overview

The global oscillating positive expiratory pressure devices market is segmented into product type, indication, end user, and region.

Global Oscillating Positive Expiratory Pressure Devices Market by Product Type

Based on the product type, it is segmented into face mask PEP devices, mouthpiece PEP devices, and bottle PEP devices. The mouthpiece PEP devices segment is anticipated to dominate the market during the forecast period. These innovative devices have garnered widespread attention and adoption among patients with respiratory conditions, such as chronic obstructive pulmonary disease (COPD), asthma, and bronchiectasis. The mouthpiece PEP devices offer several advantages, including enhanced portability, ease of use, and improved patient compliance compared to traditional mask-based PEP devices. Moreover, their ability to effectively mobilize mucus, improve lung function, and reduce the risk of respiratory infections has further fueled their popularity. As healthcare providers and patients increasingly recognize the benefits of mouthpiece PEP devices, their rising demand is expected to drive remarkable growth in the oscillating PEP devices market, ultimately revolutionizing respiratory care and management for those in need.

Global Oscillating Positive Expiratory Pressure Devices Market by Indication

Based on the indication, it is segmented into COPD & asthma, bronchitis, cystic fibrosis, and others. The COPD & Asthma segment is anticipated to dominate the market during the forecast period. Due to the primary reason of tobacco use, COPD is brought on by airway blockage that makes breathing difficult. The third leading cause of death worldwide in 2019 is a chronic obstructive pulmonary disease, according to a report from the World Health Organization. Over the projected period, the segment's growth is anticipated to be boosted by increasing patient awareness of the need to create a unified platform for COPD sufferers. For instance, worldwide, November is recognized as National COPD Month. The COPD (chronic obstructive pulmonary disease) Foundation teams up with a number of respiratory healthcare organizations to organize a number of online and offline events for COPD community members to increase exposure. heance, all such factor will fuel the segment as well as market growth.

Global Oscillating Positive Expiratory Pressure Devices Market by End User

Based on end user, it is segmented into hospital & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment is anticipated to dominate the market during the forecast period. Hospital oscillating positive expiratory pressure (OPEP) devices are expected to be more in demand as a result of the increase of hospitals, especially in developed countries. Furthermore, the segment's growth is supported by the presence of a well-developed infrastructure and the availability of cutting-edge equipment. Additionally, as more patients are admitted to hospitals, these devices are used more frequently, which boosts revenue in hospital pharmacies.

Moreover, increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and bronchiectasis has led to a rise in the demand for effective airway clearance devices in medical settings. OPEP devices have gained popularity in hospitals and clinics due to their ability to help patients clear mucus from their airways, improve lung function, and reduce the risk of exacerbations. Additionally, advancements in technology and the introduction of portable and user-friendly OPEP devices have further fueled their adoption in healthcare facilities. As a result, the hospital and clinics segment is expected to continue experiencing positive growth as healthcare providers recognize the importance of these devices in enhancing respiratory care and patient outcomes.

Geographical Analysis of the Global Oscillating Positive Expiratory Pressure Devices Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North American region is anticipated to dominate the market during the forecast period. Asthma affects 1 in 13 persons, according to a 2019 report from the Centers for Disease Control and Prevention (CDC). Asthma affects more than 25 million Americans. This represents 8.4% of kids and 7.7% of adults. All age, sex, and racial groups have shown an increase in asthma cases since the early 1980s. The American Academy of Allergy, Asthma and Immunology (AAAI) estimates that in 2016, 8.3% of American children were diagnosed with asthma. Boys had an overall higher prevalence of asthma than girls, with rates of 9.2% and 7.4%, respectively. Children's asthma incidence rose from 8.7% in 2001 to 9.4% in 2010, then fell to 8.3% in 2016. Though not all adjustments were statistically significant. Thus, aforementioned factors will drive the market growth in North America during the forecast period.

Moreover, OPEP devices are increasingly recognized as effective respiratory therapy tools for patients with various pulmonary conditions, such as chronic obstructive pulmonary disease (COPD), asthma, and bronchiectasis. The rising prevalence of respiratory disorders, coupled with the growing geriatric population, has fueled the demand for these devices in the region. Additionally, advancements in technology, leading to the development of more user-friendly and portable OPEP devices, have further driven market adoption. Moreover, an increasing focus on home-based healthcare solutions and a growing emphasis on preventive care are likely to bolster the market's expansion. As a result, key market players are investing in research and development activities to innovate and launch new OPEP devices, thereby contributing to the market's growth in North America.

Major Players in the Global Oscillating Positive Expiratory Pressure Devices Market

The major players studied in the global oscillating positive expiratory pressure devices market are AirPhysio, Allergan plc., D-R Burton Healthcare, Medica Holdings, LLC., Monaghan Medical Corporation, PARI GmbH, R. Cegla GmbH & Co. KG, Smiths Medical, Inc., and WyMedical Pty Ltd among others.

COVID-19 Impact

The COVID-19 pandemic has had a significant impact on the oscillating positive expiratory pressure (OPEP) devices market. As the virus primarily targets the respiratory system, there has been a heightened focus on respiratory care and management, driving the demand for OPEP devices. These devices, which aid in clearing mucus and improving lung function, have been increasingly adopted in both clinical settings and home care, as patients and healthcare providers recognize their benefits in mitigating the effects of COVID-19 and other respiratory illnesses. Additionally, the growing awareness of the importance of respiratory health and the need to bolster healthcare infrastructure have further fueled the market's expansion. However, disruptions in the global supply chain, regulatory challenges, and economic uncertainties during the pandemic have posed some hurdles to the market's growth. Nonetheless, the long-term prospects for the OPEP devices market remain promising as the world adapts to a new normal with a greater emphasis on respiratory well-being.

Recent Developments

• In April 2021, Smiths Medical launched the acapella choice blue vibratory PEP therapy system. Acapella is designed to aid in removing secretions for patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, lung disease with secretory problems, and patients with atelectasis.
• In May 2021, Monaghan Medical Corporation and Captis announced their agreement to a three year contract creating a partnership between the industry leaders. The sole source agreement recognizes the value of Monaghan’s patient outcome evidence and gold standard medical devices, with Captis’ desire to drive process efficiencies and value driven healthcare spending.
• In January 2021, AirPhysio, indicated for use as a Positive Expiratory Pressure (PEP) Device, received approval from the United States Food and Drug Administration.
• In February 2020, Smiths Medical Announced Launch Of Oscillatory Positive Expiratory Pressure Educational Programme On Doctors.net.uk

Oscillating Positive Expiratory Pressure Devices Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Oscillating Positive Expiratory Pressure Devices Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of Oscillating Positive Expiratory Pressure Devices Market in terms of revenue ($Million).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Oscillating Positive Expiratory Pressure Devices industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the Oscillating Positive Expiratory Pressure Devices Market along with the current trends and future estimations to depict imminent investment pockets. The overall Oscillating Positive Expiratory Pressure Devices industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Oscillating Positive Expiratory Pressure Devices Market are also analyzed.

Frequently Asked Questions

Q1. How big is the Oscillating Positive Expiratory Pressure Device market?

Ans. The global Oscillating Positive Expiratory Pressure Device market size was USD 125.7 million in 2022 and it is anticipated to grow further till USD 208.9 million by 2032, at a CAGR of 5.2% from 2023 to 2032.

Q2. What is the Oscillating Positive Expiratory Pressure Device market growth rate?

Ans. The growth rate of the Oscillating Positive Expiratory Pressure Device market is 5.2%.

Q3. Which region holds a major market share for the Oscillating Positive Expiratory Pressure Device market?

Ans. North America holds a major market share of the Oscillating Positive Expiratory Pressure Device market in 2021.

Q4. Which segment accounted for the largest Oscillating Positive Expiratory Pressure Device market share?

Ans. By end use, the hospitals & clinics segment accounted for the largest Oscillating Positive Expiratory Pressure Device market share.

Q5. Who are the key players in the Oscillating Positive Expiratory Pressure Device market?

Ans. The global Oscillating Positive Expiratory Pressure Device market report includes players such as AirPhysio, Allergan plc., D-R Burton Healthcare, Medica Holdings, LLC., Monaghan Medical Corporation, PARI GmbH, R. Cegla GmbH & Co. KG, Smiths Medical, Inc., and WyMedical Pty Ltd among others.

Q6. What are the factors driving the Oscillating Positive Expiratory Pressure Device market growth?

Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.

Q7. What are the key growth strategies of Oscillating Positive Expiratory Pressure Device market players?

Ans. The key growth strategies of Oscillating Positive Expiratory Pressure Device market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Oscillating Positive Expiratory Pressure Device market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Oscillating Positive Expiratory Pressure Device market during the forecast period.


Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.